US 6251861
Treatment of cerebral infarction using cyclic hexapeptides
expired A61KA61K38/08A61K38/12
Quick answer
US patent 6251861 (Treatment of cerebral infarction using cyclic hexapeptides) held by Takeda Chemical Industries Ltd. expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Takeda Chemical Industries Ltd.
- Grant date
- Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/08, A61K38/12